Screening and Characterization of Drugs That Protect Corneal Endothelial Cells Against Unfolded Protein Response and Oxidative Stress

Overview

Journal Invest Ophthalmol Vis Sci

Specialty Ophthalmology

Date 2017 Feb 5

PMID 28159976

Citations 15

Authors

Eun Chul Kim

Tetsuya Toyono

Cynthia A Berlinicke

Donald J Zack

Ula Jurkunas

Tomohiko Usui

Albert S Jun

Affiliations

Soon will be listed here.

Abstract

Purpose: To screen for and characterize compounds that protect corneal endothelial cells against unfolded protein response (UPR) and oxidative stress.

Methods: Bovine corneal endothelial cells (BCECs) were treated for 48 hours with 640 compounds from a Food and Drug Administration (FDA)-approved drug library and then challenged with thapsigargin or H2O2 to induce UPR or oxidative stress, respectively. Cell viability was measured using the CellTiter-Glo survival assay. Selected "hits" were subjected to further dose-response testing, and their ability to modulate expression of UPR and oxidative stress markers was assessed by RT-PCR, Western blot, and measurement of protein carbonyl and 8-hydroxydeoxyguanosine (8-OHdG) adducts in immortalized human corneal endothelial cells (iHCECs).

Results: Forty-one drugs at 20 μM and 55 drugs at 100 μM increased survival of H2O2-challenged cells, and 8 drugs at 20 μM and 2 drugs at 100 μM increased survival of thapsigargin-challenged cells, compared with untreated control cells. Nicergoline, ergothioneine, nimesulide, oxotremorine, and mefenamic acid increased survival of both H2O2- and thapsigargin-challenged cells. Oxotremorine altered DNA damage inducible 3 (CHOP) gene expression, glucose-regulated protein 78 kDa (GRP78) and activating transcription factor 4 (ATF4) protein expression, and protein carbonyl and 8-OHdG levels. Mefenamic acid altered GRP78 protein expression and protein carbonyl and 8-OHdG levels.

Conclusions: Oxotremorine and mefenamic acid are potential survival factors for corneal endothelial cells under UPR and oxidative stress. The described assay can be further expanded to screen additional drugs for potential therapeutic effect in corneal endothelial diseases such as Fuchs' endothelial corneal dystrophy.

Citing Articles

Non-apoptotic regulated cell death in Fuchs endothelial corneal dystrophy.

Sakakura S, Inagaki E, Sayano T, Yamazaki R, Fusaki N, Hatou S Regen Ther. 2023; 24:592-601.

PMID: 38034859 PMC: 10681880. DOI: 10.1016/j.reth.2023.11.001.

Cell derived matrices from bovine corneal endothelial cells as a model to study cellular dysfunction.

Jalilian I, Muppala S, Ali M, Anderson J, Phinney B, Salemi M Exp Eye Res. 2022; 226:109303.

PMID: 36343671 PMC: 11349083. DOI: 10.1016/j.exer.2022.109303.

Mitochondrial protective effects caused by the administration of mefenamic acid in sepsis.

Dominguini D, Michels M, Wessler L, Streck E, Barichello T, Dal-Pizzol F J Neuroinflammation. 2022; 19(1):268.

PMID: 36333747 PMC: 9636698. DOI: 10.1186/s12974-022-02616-6.

Effect of Physiological Oxygen on Primary Human Corneal Endothelial Cell Cultures.

Patel S, Calle Gonzalez B, Paone N, Mueller C, Floss J, Sousa M Transl Vis Sci Technol. 2022; 11(2):33.

PMID: 35191961 PMC: 8883143. DOI: 10.1167/tvst.11.2.33.

Mesenchymal Stem Cell-Derived Extracellular Vesicles Protect Human Corneal Endothelial Cells from Endoplasmic Reticulum Stress-Mediated Apoptosis.

Buono L, Scalabrin S, De Iuliis M, Tanzi A, Grange C, Tapparo M Int J Mol Sci. 2021; 22(9).

PMID: 34066474 PMC: 8125791. DOI: 10.3390/ijms22094930.

References

Schmedt T, Chen Y, Nguyen T, Li S, Bonanno J, Jurkunas U . Telomerase immortalization of human corneal endothelial cells yields functional hexagonal monolayers. PLoS One. 2013; 7(12):e51427. PMC: 3528758. DOI: 10.1371/journal.pone.0051427. View

Holtz W, Turetzky J, Jong Y, OMalley K . Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics. J Neurochem. 2006; 99(1):54-69. DOI: 10.1111/j.1471-4159.2006.04025.x. View

Grudt T, Usowicz M, Henderson G . Ca2+ entry following store depletion in SH-SY5Y neuroblastoma cells. Brain Res Mol Brain Res. 1996; 36(1):93-100. DOI: 10.1016/0169-328x(95)00248-q. View

Suh L, Zhang C, Chuck R, Stark W, Naylor S, Binley K . Cryopreservation and lentiviral-mediated genetic modification of human primary cultured corneal endothelial cells. Invest Ophthalmol Vis Sci. 2007; 48(7):3056-61. DOI: 10.1167/iovs.06-0771. View

Elhalis H, Azizi B, Jurkunas U . Fuchs endothelial corneal dystrophy. Ocul Surf. 2010; 8(4):173-84. PMC: 3061348. DOI: 10.1016/s1542-0124(12)70232-x. View

Vedana G, Villarreal Jr G, Jun A . Fuchs endothelial corneal dystrophy: current perspectives. Clin Ophthalmol. 2016; 10:321-30. PMC: 4762439. DOI: 10.2147/OPTH.S83467. View

Engler C, Kelliher C, Speck C, Jun A . Assessment of attachment factors for primary cultured human corneal endothelial cells. Cornea. 2009; 28(9):1050-4. DOI: 10.1097/ICO.0b013e3181a165a3. View

Rogers T, Inesi G, Wade R, Lederer W . Use of thapsigargin to study Ca2+ homeostasis in cardiac cells. Biosci Rep. 1995; 15(5):341-9. DOI: 10.1007/BF01788366. View

Petersen A, Carlsson T, Karlsson J, Zetterberg M . Intracellular effects of NSAIDs/ASA in oxidatively stressed human lens epithelial cells in culture. Ophthalmic Res. 2008; 40(2):77-85. DOI: 10.1159/000113885. View

10.

Azizi B, Ziaei A, Fuchsluger T, Schmedt T, Chen Y, Jurkunas U . p53-regulated increase in oxidative-stress--induced apoptosis in Fuchs endothelial corneal dystrophy: a native tissue model. Invest Ophthalmol Vis Sci. 2011; 52(13):9291-7. PMC: 3250096. DOI: 10.1167/iovs.11-8312. View

11.

Huang S, Cheng H, Tang C, Nien M, Huang Y, Lee I . Anti-oxidative, anti-apoptotic, and pro-angiogenic effects mediate functional improvement by sonic hedgehog against focal cerebral ischemia in rats. Exp Neurol. 2013; 247:680-8. DOI: 10.1016/j.expneurol.2013.03.004. View

12.

Hung J, Su I, Lei H, Wang H, Lin W, Chang W . Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase. J Biol Chem. 2004; 279(45):46384-92. DOI: 10.1074/jbc.M403568200. View

13.

Nguyen T, Bonanno J . Bicarbonate, NBCe1, NHE, and carbonic anhydrase activity enhance lactate-H+ transport in bovine corneal endothelium. Invest Ophthalmol Vis Sci. 2011; 52(11):8086-93. PMC: 3208007. DOI: 10.1167/iovs.11-8086. View

14.

Chiu A, Mandziuk J, Loganathan S, Alka K, Casey J . High Throughput Assay Identifies Glafenine as a Corrector for the Folding Defect in Corneal Dystrophy-Causing Mutants of SLC4A11. Invest Ophthalmol Vis Sci. 2015; 56(13):7739-53. DOI: 10.1167/iovs.15-17802. View

15.

Zhang , Chung , OLDENBURG . A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen. 2000; 4(2):67-73. DOI: 10.1177/108705719900400206. View

16.

Yesilot S, Ozer M, Bayram D, Oncu M, Karabacak H, Cicek E . Effects of aspirin and nimesulide on tissue damage in diabetic rats. Cytokine. 2010; 52(3):163-7. DOI: 10.1016/j.cyto.2010.07.004. View

17.

Borderie V, Baudrimont M, Vallee A, Ereau T, Gray F, Laroche L . Corneal endothelial cell apoptosis in patients with Fuchs' dystrophy. Invest Ophthalmol Vis Sci. 2000; 41(9):2501-5. View

18.

Malhi H, Kaufman R . Endoplasmic reticulum stress in liver disease. J Hepatol. 2010; 54(4):795-809. PMC: 3375108. DOI: 10.1016/j.jhep.2010.11.005. View

19.

Engler C, Kelliher C, Spitze A, Speck C, Eberhart C, Jun A . Unfolded protein response in fuchs endothelial corneal dystrophy: a unifying pathogenic pathway?. Am J Ophthalmol. 2010; 149(2):194-202.e2. PMC: 2813215. DOI: 10.1016/j.ajo.2009.09.009. View

20.

Jurkunas U, Bitar M, Funaki T, Azizi B . Evidence of oxidative stress in the pathogenesis of fuchs endothelial corneal dystrophy. Am J Pathol. 2010; 177(5):2278-89. PMC: 2966787. DOI: 10.2353/ajpath.2010.100279. View